首页|冠心病中成药治疗的门诊处方分析及合理性评估

冠心病中成药治疗的门诊处方分析及合理性评估

扫码查看
目的 通过收集并探讨分析武汉市某医院用于治疗冠心病的中成药门诊处方,总结关于冠心病中医辨证施治及中成药处方的规律.方法 调取 2023 年 12 月至 2024 年 4 月医院实施处方点评后开具的 1000 张处方,对其中治疗冠心病中成药的使用情况进行统计,并对冠心病患者中成药处方药物种类、使用频率、使用合理情况进行分析.结果 在1000 张中成药处方中,最常用的中成药有 10 种,活血化瘀和化瘀止血类药物使用频率居于前列,其中麝香保心丸(21.00%)、速效救心丸(10.90%)、复方丹参滴丸(10.20%)较为常见.中成药主要药物组成有 34 种,前三位药物为丹参(12.63%)、川芎(10.05%)及人参/红参(9.80%).在 1000 张处方中,不合理处方有 234 张,占 23.40%,其中不规范处方有 139 张(59.40%),主要存在问题:内容缺失有 54 张(23.07%),疗程不当有 46 张(19.65%),缺少中医辨证有 39 张(16.67%).用药不适宜处方有 87 张(37.17%),主要存在问题:适应证不适宜有 47 张(20.08%),用量、用法不适宜有 40 张(17.09%).其他不适宜处方有 8 张(3.42%).结论 治疗冠心病的中成药种类较多,在用药过程中,需注意中医辨证及用药监护,进一步加强合理用药,提高用药水平.
Analysis And Rationality Evaluation of Outpatient Prescription for Coronary Heart Disease Treated with Chinese Patent Medicine
Objective:To collect and analyze the outpatient prescriptions of Chinese patent medicine for treating coronary heart disease in a hospital in Wuhan,and summarize the rules of TCM syndrome differentiation and treatment of coronary heart disease and Chinese patent medicine prescriptions.Methods:1000 prescriptions issued by the hospital from December 2023 to April 2024 were collected,and the use of proprietary Chinese medicines in patients with coronary heart disease was counted,and the types、frequency and rational use of proprietary Chinese medicines in patients with coronary heart disease were analyzed.Results:Among 1000 prescriptions of Chinese patent medicines,there are 10 kinds of Chinese patent medi-cines that are most commonly used,among which drugs for promoting blood circulation and removing blood stasis and stopping bleeding are in the forefront,among which Musk Baoxin Pill(21.00%),Suxiao Jiuxin Pill(10.90%)and Com-pound Danshen Dropping Pill(10.20%)are more common.There are 34 kinds of main Chinese patent medicines,and the top three medicines are Danshen(12.63%),Chuanxiong(10.05%)and Ginseng/Ginseng Rubra(9.80%).Among the 1000 prescriptions,234 were irrational prescriptions,accounting for 23.40%,of which 139 were nonstandard prescriptions(59.40%).The main problems were:54 were lack of content(23.07%),46 were improper treatment(19.65%)and 39 were lack of TCM syndrome differentiation(16.67%).There are 87 prescriptions(37.17%)that are not suitable for med-ication,and the main problems are:47 prescriptions are not suitable for indications(20.08%),and 40 prescriptions are not suitable for dosage and usage(17.09%).There were 8 other inappropriate prescriptions(3.42%).Conclusion:There are many kinds of Chinese patent medicines for treating coronary heart disease.In the process of medication,we should pay at-tention to TCM syndrome differentiation and medication monitoring,further strengthen rational medication and improve the level of medication.

Coronary heart diseaseChinese patent medicinePrescription analysisTCM syndrome differentiation and treatmentRational administration of drugs

杜泽仁、李然然

展开 >

武汉文理学院药学院,湖北武汉 430101

冠心病 中成药 处方分析 中医辨证施治 合理用药

2024

生命科学仪器
北京市北分仪器技术公司

生命科学仪器

影响因子:0.305
ISSN:1671-7929
年,卷(期):2024.22(3)
  • 9